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Role of Vitamin D in Improvement in Changes of Podocyte 
P-Cadherin/β-Catenin Complex Induced by Diabetic 
Conditions
Jae Il Shin,1 Hye-Young Park,2 Se Jin Park,3 Tae-Sun Ha4
Introduction. This study aimed to investigate the effect of vitamin 
D on the pathologic changes of podocyte β-catenin and P-cadherin 
and podocyte permeability induced by diabetic conditions. 
Materials and Methods. We cultured mouse podocytes under normal 
glucose (5 mM, control); high glucose (HG, 30 mM); advanced 
glycosylation end products (AGE)-added; and HG plus AGE-added 
conditions and treated with vitamin D. The distribution of podocyte 
β-catenin and P-cadherin was shown by confocal microscopy, and 
protein levels of β-catenin and P-cadherin by Western blotting. 
Podocytes were incubated with vitamin D at the concentrations 
of 10 nM and 50 nM for 6, 24, and 48 hours. 
Results. The dextran filtration through monolayered podocytes 
tended to increase in AGE and HG condition compared to that 
in B5 at 16 hours in permeability assay, which was improved by 
vitamin D. In confocal imaging, the distribution of β-catenin and 
P-cadherin were internally concentrated by diabetic conditions, 
which was ameliorated by vitamin D. In Western blotting, HG 
and AGE decreased β-catenin protein levels at 6, 24, and 48 hours 
and vitamin D improved the decreased β-catenin protein levels 
at 6, 24, and 48 hours. Advanced glycosylation end products also 
decreased P-cadherin protein amount by 22.9% and 59.1% (P < .01) 
at 24 hours, respectively, which was improved by vitamin D. 
Conclusions. Our results suggest that HG and AGE have an influence 
on the redistribution of β-catenin and P-cadherin and amount of 
β-catenin protein of podocytes, thereby causing hyperpermeability, 
which can be reversed by vitamin D.
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INTRODUCTION
Diabetic nephropathy is a major cause of end-stage 
renal failure in adults, but the pathophysiologic 
m e c h a n i s m s  r e m a i n s  e l u s i v e . 1 , 2  D i a b e t i c 
nephropathy is characterized by hyperfiltration 
and microalbuminuria at an early stage, but can 
progress to severe proteinuria and kidney failure.1-3 
Hyperglycemia and advanced glycosylation end 
products (AGE) in diabetic conditions can change 
renal pathology, such as glomerular hypertrophy, 
increase of mesangial matrix, thickening of 
glomerular basement membrane, and effacement 
of podocyte foot processes, which can result in 
increase in glomerular permeability.1,3-5 
Podocytes are highly differentiated epithelial 
cells, covering the outer layer of the glomerular 
basement membrane, and the foot processes of 
podocytes are interdigitated and bridged by a 
zipper-like structure, the slit diaphragm (SD).6-8 
As a size-selective barrier, the SD is composed 
of adherens junction proteins, such as nephrin, 
P-cadherin, NEPH1, and F-actin, with the filtration 
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slit of 25-nm to 60-nm width and is connected to 
the actin cytoskeletons by adaptor proteins, such 
as CD2-associated protein, zonula occludens-1, 
β-catenin, and podocin.6-8 β-Catenin is present in 
podocytes as 2 forms: one is located in the plasma 
membrane as a cadherin/catenin adhesive complex 
that stabilizes adherens junctions by maintaining 
epithelial integrity and the other in the nucleus as 
a key regulator of gene expression via binding to 
transcription factors (for example, T-cell factor or 
lymphoid enhancer-binding factor).8,9 
Recent reports suggested that vitamin D 
has an important role in renoprotection in 
diabetic conditions by multiple mechanisms, 
such as inhibiting the renin-angiotensin system, 
inflammatory cascades, Wnt/β-catenin pathway, 
and pro-apoptotic pathway.10-14 However, there 
have been very few data regarding the effects of 
vitamin D on podocyte SD or adaptor molecules in 
diabetic conditions.15,16 Some investigators showed 
that vitamin D might upregulate the expression 
of podocyte components, such as podocalyxin 
or nephrin,15,16 but limited data were available 
regarding the effects of vitamin D on other SD 
or adaptor molecules, such as P-cadherin/β-
catenin adhesive complex. The aim of this study 
was to investigate the effect of vitamin D on the 
pathologic changes of podocyte P-cadherin and 
β-catenin and podocyte permeability induced by 
diabetic conditions.
MATERIALS AND METHODS
Culture of Mouse Podocytes
Mouse podocytes were conditionally immortalized 
and were provided by Dr Peter Mundel (University 
of Harvard, Boston, MA, USA). Those were cultured 
and differentiated as reported previously.17 In brief, 
for proliferation of podocytes, cells were cultivated 
at 33°C in a culture medium supplemented with 10 
U/mL of mouse recombinant γ-interferon (Roche, 
Mannheim, Germany) to induce expression of 
temperature-sensitive large T antigen (permissive 
conditions). For differentiation of podocytes, cells 
were maintained at 37°C without γ-interferon for 
at least 14 days (nonpermissive conditions).17
Culture Additives
Cells  were deprived of  serum to reduce 
background 24 hours before each experiment, and 
then were exposed to glucose or AGE or both. 
Mouse podocytes were incubated in culture media, 
which contained either 5 mM (normal glucose) 
or 30 mM glucose (high glucose, HG) without 
insulin. Advanced glycosylation end products were 
produced by the technique previously described 
by Ha and colleagues.18 To emulate the long-term 
diabetic condition, AGE was added (5 µg/mL) and 
controls were made by using unmodified bovine 
serum albumin (5 µg/mL). In order to exclude the 
effect of additionally produced glycated proteins 
in culture conditions, incubation period was not 
longer than 48 hours. Fetal bovine serum was 
decreased to 0.5% in the last media change to reduce 
background before protein extraction. Advanced 
glycosylation end products and bovine serum 
albumin were denoted as ‘A’ and ‘B,’ and glucose 
at 5 mM and 30 mM as ‘5’ and ‘30’, respectively, 
for identification. Namely, B5 means normal, 
B30 short-term diabetic condition, A5 long-term 
normoglycemic or aged condition, and A30 long-
term diabetic condition.
For vitamin D treatment, podocytes were 
incubated with 1,25-dihydroxyvitamin D3 (Sigma) at 
the concentrations of 10 nM for 6, 24, and 48 hours.
Monolayer Permeability Assay
Podocytes were seeded and confluently grown 
in a monolayer pattern on the surface of cellulose 
semi-permeable membranes (Millicell-HA, Millipore 
Corp, Bedford, MA, USA), which have a pore size of 
0.45 µm. After the previously described media was 
washed completely, fresh media for maintenance 
without AGE and bovine serum albumin were 
replaced into each aspect. Then, hydrostatic 
pressure was continuously applied from lower to 
apical to the basolateral aspect. Then, 1 mg/mL of 
fluorescein isothiocyanate-tagged anionic dextran 
(Invitrogen, Eugene, OR, USA) was added into the 
apical media and the filtered amounts of dextran at 
each incubation time (2, 4, 6, 16, 24, and 100 hours) 
were measured by spectrophotometer at 492 nm.
Confocal Image Analysis
Mouse podocytes were grown on glass cover 
slips, in which type I collagen were coated and 
those were incubated for 24 hours and then fixed in 
4% paraformaldehyde, permeabilized in phosphate 
buffer saline, blocked with 10% normal goat serum, 
and labeled with polyclonal rabbit anti-rat β-catenin 
(Santa Cruz Biotechnology Inc, Santa Cruz, CA, 
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USA) or polyclonal rabbit anti-P-cadherin (Santa 
Cruz Biotechnology Inc, Santa Cruz, CA, USA). 
Primary antibody-bound specimens were incubated 
with 1:500 (v/v) Alexa 594 for red conjugates 
(Molecular Probes, Invitrogen, Carlsbad, CA, USA) 
and Alexa 488 for green, respective of secondary 
antibodies, at room temperature for 1 hour. 
Coverslips were mounted in aqueous mountant 
and viewed with a fluorescence microscope (BX51, 
Olympus, Tokyo, Japan).
Western Blotting
The confluently grown cell layers were incubated 
with additives during 48 hours for β-catenin and 
P-cadherin and then various durations for AGE 
were extracted and protein concentrations were 
determined as previously described.18 For the 
Western blotting of β-catenin, 30 µg of boiled 
extracts was applied on 10% sodium dodecyl 
sulfate polyacrylamide gel electrophoresis gels and 
transferred to polyvinylidene fluoride membranes 
(Bio-Rad Laboratories, Hercules, CA, USA). Then, 
the membranes were air-dried and blocked in 3% 
fat-free milk before incubation with anti-β-catenin 
antibody. After incubation with horseradish 
peroxidase-conjugated secondary antibodies 
(Santa Cruz Biotechnology Inc, Santa Cruz, CA, 
USA), bands were detected by using the enhanced 
chemiluminescence system (Amersham Biotech Ltd., 
Bucks, UK). The Western blotting of P-cadherin 
was also performed with a same protocol. Data on 
the densitometric analysis of β-catenin/β-tubulin 
ratio were expressed as mean ± standard deviation. 
Three independent experiments were performed.
Statistical Analysis
Statistical analysis was performed by the SPSS 
software (Statistical Package for the Social Sciences, 
version 12.0, SPSS Inc, Chicago, Ill, USA). The 
results were shown as mean ± standard deviation 
and the statistical significance was analyzed by the 
Student t test and nonparametric Kruskal-Wallis 
test. P values of less than .05 were considered 
significant. 
RESULTS
Increased Permeability by High Glucose and 
Advanced Glycosylation End Products
The dextran filtration of monolayered podocytes 
tended to increase in AGE (A30) than in B5 at 16 hours 
in permeability assay (Figure 1). Increased podocyte 
permeability by AGE (A30) was improved by vitamin 
D (Figure 1). These results indicated that vitamin 
D might improve podocyte hyperpermeability 
induced by AGE in diabetic conditions.
Changes of β-Catenin and P-Cadherin in 
Confocal Imaging
Changes of β-catenin and P-cadherin on confocal 
imaging in diabetic conditions are shown in (Figure 2). 
In confocal imaging, staining for β-catenin and 
P-cadherin was most intense in the cell membrane. 
In merged views, the distribution of β-catenin and 
P-cadherin were colocalized. In diabetic conditions, 
β-catenin moved toward the cytoplasm from the 
cell membrane at B30, A5, and A30, compared 
Figure 1. Effects of vitamin D on the increased monolayered 
podocyte permeability in diabetic conditions. Podocyte 
permeability tended to increase in advanced glycosylation end 
products and high glucose condition (A30) as compared to that 
in normal condition with 5 mM glucose (B5 at 16 hours), which 
was improved by vitamin D.
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Figure 2. Changes in distribution of β-catenin and P-cadherin in diabetic conditions and vitamin D treatment (× 1000). β-Catenin was 
colocalized with P-cadherin at cell membrane areas. Top, Diabetic conditions (B30, A5, and A30) decreased the immunostainings and 
disrupted the distributions of β-catenin and (arrows). Middle and Bottom, Changes of β-catenin and P-cadherin were improved by 
vitamin D.
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with B5 and were internally concentrated (arrows, 
Figure 2 Top). Moreover, intercellular staining of 
β-catenin was decreased. A similar redistribution 
of P-cadherin was also observed in podocytes with 
internal concentration and decreased intercellular 
staining. In merged views, β-catenin and P-cadherin 
were distributed at the cell membrane at B5 but 
redistributed into the cytoplasm at B30, A5, and 
A30, suggesting that high glucose and AGE might 
have an impact on the redistribution of β-catenin 
and P-cadherin in podocytes (Figure 2 Top).
1,25-dihydroxyvitamin D3 (10 nM and 50 nM) 
improved the decreased and internally concentrated 
β-catenin and P-cadherin immunostaining to be as 
those in B5 (Figure 2 Middle and Bottom). These 
findings indicated that glucose and AGE might 
affect the amount and redistribution of β-catenin 
and P-cadherin of podocytes, thereby causing 
hyperpermeability, which could be reversed by 
vitamin D.
Western Blotting of β-Catenin in Podocytes
In Western blotting (Figure 3), density values for 
β-catenin protein of representative immunoblots 
from each group revealed that decreased β-catenin 
protein levels in A30 at 6, 24, and 48 hours (P < .01). 
A30 condition decreased β-catenin protein amount 
by 32.5% at 6 hours, 31.8% at 24 hours, and by 26.7% 
at 48 hours incubation (P < .01; Figure 3). High 
glucose (B30) condition also decreased β-catenin 
protein amount by 24.7% at 6 hours and 31.8% at 
24 hours incubation, but it was not statistically 
significant (Figure 3A). 1,25-dihydroxyvitamin D3 
(10 nM) treatment in A30 significantly improved 
the decreased β-catenin protein levels at 6, 24, and 
48 hours incubation times (Figure 3B). 
A5 and A30 condition decreased P-cadherin 
protein amount by 22.9% (P < .05) and 59.1% 
(P < .01) at 24 hours, respectively, which was 
improved by 1,25-dihydroxyvitamin D3 (10 nM, 
P < 0.01 and 50 nM, P < 0.05) treatment (Figure 3C).
Figure 3. Effects of diabetic conditions and vitamin D on the 
β-catenin and P-cadherin protein by Western blotting. The major 
band for β-catenin protein decreased in A30 condition at 6, 24, 
and 48 hours incubations, which were improved by vitamin 
D (10 nM) (A and B). The A5 and A30 conditions decreased 
P-cadherin protein amount at 24 hours, which was improved by 
vitamin D (C). 
*P < .05 versus control
†P < .01 versus control
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DISCUSSION
Regardless of the underlying causes, the presence 
of proteinuria suggest ultrastructural changes in 
podocytes, such as with retraction and effacement 
of the interdigitating foot processes, which were 
accompanied by the alterations of SD and associated 
molecules.6,8,19,20 
Among various adaptor proteins of podocytes, 
β-catenin has dual functions according to the 
subcellular localization. β-Catenin is a component 
of the P-cadherin/β-catenin complex which 
stabil izes podocyte adherens junctions for 
maintenance of SD integrity and it is linked to the 
podocyte cytoskeletons.6,8,19,20 However, β-catenin 
also regulates gene expression by binding to 
transcription factors such as T-cell factor and 
lymphoid enhancer-binding factor in the nucleus 
and this canonical pathway, which regulates 
β-catenin involves glycogen synthase kinase-3β/
Wnt signaling.8,21 
Previous studies have mainly focused on the 
changes of Wnt/β-catenin signaling, because 
it has been regarded as an important player in 
the pathogenesis of podocyte dysfunction and 
albuminuria.9,10 Dai and coworkers10 reported 
that overexpression of Wnt1 in vivo activated 
glomerular β-catenin and aggravated albuminuria 
and adriamycin-induced suppression of nephrin 
expression, whereas blockade of Wnt signaling with 
Dickkopf-1 ameliorated podocyte lesions, suggesting 
that the hyperactive Wnt/β-catenin signaling is 
a crucial mediator in inducing podocyte injury. 
However, there have been scarce data regarding the 
effects of diabetic conditions on podocyte β-catenin 
as a P-cadherin/ β-catenin adhesive complex. 
Recent studies showed that the SD is a modified 
adherens junction rather than a tight junction, at 
which P-cadherin is localized.7 Cadherins are a 
superfamily of glycoproteins that mediate calcium-
dependent, homotypic cell-cell adhesion in solid 
tissues and there are E (epithelial)-, N (neural)- 
and P (placental)-cadherins.22 They are known to 
play important roles in maintaining the structural 
integrity of epithelial tissues,22 and P-cadherin is 
known to serve as a basic scaffold for the SD.7 
Our results showed that HG and AGE had an 
influence on the redistribution of β-catenin and 
P-cadherin and amount of β-catenin protein of 
podocytes, thereby causing hyperpermeability, 
which can be reversed by vitamin D. Although 
rare, previous reports have also shown that the 
expression of P-cadherin or β-catenin was altered 
by diabetic conditions.23-25 Xu and colleagues23 
reported that HG significantly reduced P-cadherin 
mRNA and protein expression in cultured podocytes 
and glomerular P-cadherin mRNA and protein 
expressions were significantly lower in diabetic 
rats than in control rats. Ha and coworkers24 
showed that high glucose with or without AGE 
suppressed the production of P-cadherin at the 
transcriptional level and that these changes might 
explain the functional changes of SD in diabetic 
conditions. Recently, we demonstrated that AGE 
and hyperglycemia could inhibit the production of 
β-catenin at the transcriptional and posttranslational 
levels in rat glomerular epithelial cells and mouse 
podocytes.25 
In our study, the distribution of β-catenin and 
P-cadherin were colocalized in the cell membrane 
of podocytes, but intercellular staining of them 
was decreased and internally concentrated and 
β-catenin protein levels were decreased in diabetic 
conditions, suggesting that high glucose and 
AGE might have an impact on the amount and 
redistribution of P-cadherin/β-catenin adhesive 
complex in podocytes. 
In our study, we also showed that podocyte 
permeability was increased by AGE. Recently, Ha 
and colleagues26 reported that both HG- and AGE-
added condition could induce phosphoinositide 
3-kinase and its downstream mediators (Akt) and 
the distributional change and suppression of zonula 
occludens-1 protein, one of the adaptor proteins 
in podocytes, thereby causing hyperpermeability 
of podocytes.  Therefore,  we speculate that 
diabetic conditions might induce the activation 
of phosphoinositide 3-kinase/Akt and then the 
changes in downstream pathways, such as the 
zonula occludens-1 and P-cadherin/β-catenin 
adhesive complex and cell integrity, causing 
hyperpermeability subsequently in podocytes. 
Vitamin D might be important for maintaining 
podocyte health in the kidney by preventing 
epithelial-to-mesenchymal transformation, 
s u p p r e s s i n g  r e n i n  g e n e  e x p r e s s i o n  a n d 
inflammation.11 Wang and colleagues12 reported 
that 1,25-dihydroxyvitamin D suppressed high-
glucose-induced apoptosis of podocytes by blocking 
p38- and ERK-mediated proapoptotic pathways 
and Sanchez-Niño and colleagues13 showed that 
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vitamin D receptor activation by calcitriol and 
paricalcitol reduced monocyte chemoattractant 
protein-1, and interleukin-6 in podocytes and 
tubular cells as well as glomerular infiltration by 
macrophages, glomerular cell NF-κB activation, 
apoptosis, and extracellular matrix deposition. Deb 
and colleagues14 demonstrated that angiotensinogen 
mRNA expression in the kidney was markedly 
increased in mice lacking the vitamin D receptor, 
compared with wild-type mice, and angiotensinogen 
induction in diabetic mice was suppressed by 
treatment with a vitamin D analog, indicating 
that vitamin D suppresses hyperglycemia-induced 
angiotensinogen expression by blocking NF-κB-
mediated pathway.
Nevertheless, there have been scarce data 
regarding the effects of vitamin D on podocyte SD 
molecules or adaptor proteins in diabetic conditions. 
Verouti and colleagues15 reported that vitamin D 
analogues reactivate the expression of specialized 
podocyte components, including podocalyxin, 
and Deb and coworkers16 showed that vitamin 
D stimulates nephrin expression in podocytes by 
acting on a vitamin D response elements in the 
proximal nephrin promoter. Moreover, there have 
been no data regarding the effects of vitamin D on 
podocyte P-cadherin/β-catenin adhesive complex in 
diabetic conditions, and our results demonstrated 
that 1,25-dihydroxy vitamin D3 (10 nM) treatment 
in A30 condition significantly improved the 
decreased β-catenin protein levels at 6, 24, and 
48 hours incubation times and also decreased 
podocyte permeability, indicating that vitamin 
D might improve podocyte hyperpermeability in 
diabetic conditions by restoring β-catenin. 
B e c a u s e  t h e  p o d o c y t e  s t r u c t u r e  c a n  b e 
compromised by high glucose in vitro and diabetic 
nephropathy in vivo, and vitamin D has few side 
effects, vitamin D could be used in clinical practice, 
considering an important role in preserving 
structural integrity of the podocyte by acting on 
P-cadherin/β-catenin complex. However, there is 
a limitation of our study, because we performed in 
vitro study and the results cannot be fully applied 
to in vivo models. Therefore, our results should 
also be validated in mouse and human models of 
diabetic nephropathy in the future.
CONCLUSIONS
The results of our study suggest that diabetic 
conditions induce the distributional change and 
suppress the production of β-catenin in podocytes, 
which can be improved by vitamin D. Therefore, 
vitamin D may be helpful to prevent the pathological 
changes of podocytes in diabetic nephropathy. 
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